Else A Aalbersberg

8PUBLICATIONS
9CO-AUTHORS
Radiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Pharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 20, 2026
Radiation induced lymphopenia during PRRT: Incidence, course, predictive factors, and association with overall survival.

Gerdi G de Harder, Chayenne H A M Veerman, Milou M- Steemers-de Boer

|Jan 04, 2023
The effect of long-acting somatostatin analogues on the uptake of [177Lu]Lu-HA-DOTATATE.

Chayenne H A M Veerman, Hinke Siebinga, Daphne M V de Vries-Huizing

|Dec 14, 2022
Somatostatin receptor saturation after administration of high peptide amounts of [177Lu]Lu-HA-DOTATATE: when enough is enough.

Hinke Siebinga, Chayenne H A M Veerman, Linda de Wit-van der Veen

|Sep 27, 2022
Quality control of [177Lu]Lu-PSMA preparations using HPLC: effect of sample composition and ligand on recovery.

Else A Aalbersberg, Tammie T Cao, Martine M Geluk-Jonker

|Jun 17, 2022
Post-PRRT scans: which scans to make and what to look for.

Else A Aalbersberg, Daphne M V de Vries-Huizing, Margot E T Tesselaar

|Aug 12, 2020
Early response assessment and prediction of overall survival after peptide receptor radionuclide therapy.

Daphne M V Huizing, Else A Aalbersberg, Michelle W J Versleijen

Pageof 2